US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

OS Therapies

1.88

+0.02911.57%

Volume:142.34K

Turnover:266.85K

Market Cap:52.80M

PE:-2.29

High:1.91

Open:1.86

Low:1.81

Close:1.85

Loading ...

Overview Company News Filings

Os Therapies Agrees to Acquire All Listeria Monotygenes-Based Immuno-Oncology Programs and Ip Assets From Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostrate Cancer Programs to Pipeline

THOMSON REUTERS

OS Therapies Inc trading halted, news pending

OS Therapies price target raised to $15 from $8 at Maxim

OS Therapies Is Maintained at Buy by D. Boral Capital

Os Therapies : Maxim Group Raises Target Price to $15 From $8

THOMSON REUTERS

OS Therapies Shares Surge 60% After Clinical Trial Yields Positive Results

Wall Street Set to Open Sharply Higher Wednesday on Positive Inflation Data

MT Newswires Live

OS Therapies Says Lung Cancer Therapy Meets Primary Endpoint in Phase 2 Study

MT Newswires Live

BUZZ-OS Therapies rises after cancer therapy meets main goal in mid-stage trial

OS Therapies announces OST-HER2 trial achieves primary endpoint

Os Therapies Announces Phase 2B Clinical Trial of Ost-Her2 Achieves Primary Endpoint With Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

THOMSON REUTERS

Os Therapies Inc - Ost-Her2 Safe and Well Tolerated in Phase 2B Study

THOMSON REUTERS

OS Therapies Raises $6 Million in Private Placement of Units

MT Newswires Live

Os Therapies Announces Closing of $6 Million Private Placement

THOMSON REUTERS

Sector Update: Health Care Stocks Steady Premarket Thursday

MT Newswires Live

BRIEF-OS Therapies Announces Pricing Of $6 Million Private Placement

OS Therapies Shares Jump on $6 Million Private Placement

OS Therapies Prices $6 Million Private Placement; Shares Surge

MT Newswires Live

OS Therapies to sell 1.5M units at $4.00 in private placement

Os Therapies Announces Pricing of $6 Million Private Placement

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OSTX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","market":"US","secType":"STK","nameCN":"OS Therapies","latestPrice":1.8791,"timestamp":1750092431285,"preClose":1.85,"halted":0,"volume":142344,"delay":0,"floatShares":18778400,"shares":28097697,"eps":-0.819717,"marketStatus":"Trading","change":0.0291,"latestTime":"06-16 12:49:07 EDT","open":1.8556,"high":1.91,"low":1.81,"amount":266851.727424,"amplitude":0.054054,"askPrice":1.89,"askSize":127,"bidPrice":1.84,"bidSize":422,"shortable":3,"etf":0,"ttmEps":-0.819717,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750104000000},"marketStatusCode":2,"adr":0,"listingDate":1719460800000,"exchange":"AMEX","adjPreClose":1.85,"preHourTrading":{"tag":"盘前","latestPrice":1.88,"preClose":1.85,"latestTime":"09:26 EDT","volume":2504,"amount":4592.9166776,"timestamp":1750080390112},"postHourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.82,"latestTime":"19:38 EDT","volume":1395,"amount":2554.6518,"timestamp":1749857925129},"volumeRatio":0.465722},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","floatShares":18778400,"roa":"-263.81%","roe":"--","lyrEps":-0.879526,"volumeRatio":0.465722,"shares":28097697,"dividePrice":0,"high":1.91,"amplitude":0.054054,"preClose":1.85,"low":1.81,"week52Low":1.12,"pbRate":"-12.61","week52High":7,"institutionHeld":0,"latestPrice":1.8791,"committee":0.537341,"eps":-0.819717,"divideRate":0,"volume":142344,"delay":0,"ttmEps":-0.819717,"open":1.8556,"prevYearClose":4.28,"prevWeekClose":1.82,"prevMonthClose":1.53,"prevQuarterClose":1.54,"fiveDayClose":1.98,"twentyDayClose":1.64,"sixtyDayClose":1.59},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSTX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507396846","title":"Os Therapies Agrees to Acquire All Listeria Monotygenes-Based Immuno-Oncology Programs and Ip Assets From Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostrate Cancer Programs to Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2507396846","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507396846?lang=en_us&edition=fundamental","pubTime":"2025-01-29 22:22","pubTimestamp":1738160520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUA4S6CSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSTX","BK4139"],"gpt_icon":0},{"id":"2507639199","title":"OS Therapies Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2507639199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507639199?lang=en_us&edition=fundamental","pubTime":"2025-01-29 22:20","pubTimestamp":1738160410,"startTime":"0","endTime":"0","summary":"09:18 EST OS Therapies (OSTX) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-inc-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-inc-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"gpt_icon":0},{"id":"2504659721","title":"OS Therapies price target raised to $15 from $8 at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2504659721","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504659721?lang=en_us&edition=fundamental","pubTime":"2025-01-17 21:35","pubTimestamp":1737120952,"startTime":"0","endTime":"0","summary":"Maxim analyst Jason McCarthy raised the firm’s price target on OS Therapies  to $15 from $8 and keeps a Buy rating on the shares. The firm cites the company’s positive Phase 2b top-line data for OST-HER2 in recurrent osteosarcoma, meeting the primary endpoint of 12-month event free survival. The data now positions the company to meet with the FDA by the end of Q1 to discuss the potential for filing for accelerated approval, which would include comparison to a synthetic control already requested by the FDA and which OS Therapies has already started building, the analyst tells investors in a research note.Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. OS Therapies announces OST-HER2 trial achieves primary endpoint. OS Therapies to sell 1.5M units at $4.00 in private placement","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/os-therapies-price-target-raised-133552998.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-price-target-raised-133552998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OSTX"],"gpt_icon":0},{"id":"2503192621","title":"OS Therapies Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2503192621","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503192621?lang=en_us&edition=fundamental","pubTime":"2025-01-16 00:26","pubTimestamp":1736958360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OSTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 15, 2025 11:26 ET (16:26 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX"],"gpt_icon":0},{"id":"2503454623","title":"Os Therapies : Maxim Group Raises Target Price to $15 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2503454623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503454623?lang=en_us&edition=fundamental","pubTime":"2025-01-15 23:24","pubTimestamp":1736954668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nFWN3OB15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSTX","BK4139"],"gpt_icon":0},{"id":"2503642022","title":"OS Therapies Shares Surge 60% After Clinical Trial Yields Positive Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642022","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503642022?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:33","pubTimestamp":1736951580,"startTime":"0","endTime":"0","summary":"OS Therapies shares surged Wednesday after the biotech company reported positive data from a clinical trial for its cancer treatment OST-HER2.Shares of the N.Y., clinical-stage biotechnology company were recently up 60% to $6.64 in premarket trading, which is above the stock's 52-week high of $6.48.The trial tested whether OST-HER2 could successfully treat a rare form of bone cancer that spreads to the lungs. The company reported statistically significant results in the study's primary endpoint, which measured whether patients went 12 months without the recurrence of metastatic osteosarcoma.The company also indicated promising results from patients at the 1-year and 2-year marks.Robert Petit, the company's chief medical and scientific officer, said that the treatment would help a population for whom there are currently no approved therapies.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2503644214","title":"Wall Street Set to Open Sharply Higher Wednesday on Positive Inflation Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2503644214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503644214?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:20","pubTimestamp":1736950829,"startTime":"0","endTime":"0","summary":"US stocks look set to open sharply higher in Wednesday's trading session as investor sentiment was buoyed by encouraging inflation data released earlier in the morning.Dow Jones Industrial Average fut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GIFT","PBHC","BK4211","BK4129","SYRE","LIF","SGBX","BK4077","FUND","BK4108","BK4023","MITQ","BK4190","BK4539","BK4120","OSTX","VMAR","LICY","BK4139"],"gpt_icon":1},{"id":"2503364642","title":"OS Therapies Says Lung Cancer Therapy Meets Primary Endpoint in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503364642","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503364642?lang=en_us&edition=fundamental","pubTime":"2025-01-15 21:35","pubTimestamp":1736948150,"startTime":"0","endTime":"0","summary":"OS Therapies  said Wednesday its phase 2 OST-HER2 trial of an experimental treatment for lung metastatic osteosarcoma showed statistically significant results for the primary goal of 12-month event-free survival.The company said the interim data from the ongoing 3-year overall survival secondary endpoint showed a strong trend in favor of the company's therapy in patients at both the 1-year and 2-year time points.It added that all patients who reached the 12-month event-free survival endpoint remained alive.\"We are preparing to engage with the U.S. FDA on an accelerated pathway for approval in this extremely challenging indication,\" Paul Romness, MHP, Chair & CEO of OS Therapies, said.Shares of the company rose more than 60% in premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2503645219","title":"BUZZ-OS Therapies rises after cancer therapy meets main goal in mid-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2503645219","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503645219?lang=en_us&edition=fundamental","pubTime":"2025-01-15 21:21","pubTimestamp":1736947269,"startTime":"0","endTime":"0","summary":"** Shares of drug developer OS Therapies    rise 56.5% to $6.46 premarket    ** Co says its experimental immunotherapy met the main goal of a mid-stage trial to treat a type of bone cancer     ** Co says the therapy, OST-HER2, met the main goal of delaying the recurrence of the cancer by 12 months, compared to the historical comparable group   ** Co says all patients who achieved the 12-month event-free survival goal are alive   ** OST-HER2 was safe and well-tolerated in the study, OSTX says   ** The therapy is being tested to prevent lung metastatic osteosarcoma, a type of recurrent bone cancer that has spread to the lungs   ** Co says with these results, it is preparing to engage with U.S. FDA on \"an accelerated pathway for approval\"    ** \"We do not expect to have to treat additional patients as part of this process with FDA,\" OSTX adds    ** Stock up 65.7% since its market debut in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BUZZ-OS Therapies rises after cancer therapy meets main goal in mid-stage trial","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"gpt_icon":0},{"id":"2503648266","title":"OS Therapies announces OST-HER2 trial achieves primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2503648266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503648266?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:45","pubTimestamp":1736945112,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced data from a Phase 2b clinical trial of OST-HER2 – the company’s HER2-targeted immunotherapy candidate in the rare ped...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-ost-her2-trial-achieves-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-ost-her2-trial-achieves-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4148","BK4139","OSTX","OST"],"gpt_icon":0},{"id":"2503610225","title":"Os Therapies Announces Phase 2B Clinical Trial of Ost-Her2 Achieves Primary Endpoint With Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2503610225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503610225?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:40","pubTimestamp":1736944800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nTUA21BCWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2503610003","title":"Os Therapies Inc - Ost-Her2 Safe and Well Tolerated in Phase 2B Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503610003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503610003?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:40","pubTimestamp":1736944800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nTUA21BCWD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSTX","BK4139"],"gpt_icon":0},{"id":"2500890640","title":"OS Therapies Raises $6 Million in Private Placement of Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2500890640","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500890640?lang=en_us&edition=fundamental","pubTime":"2025-01-01 04:58","pubTimestamp":1735678699,"startTime":"0","endTime":"0","summary":"OS Therapies  said Tuesday it closed the $6 million private placement financing of 1.5 million units.Each unit in the offering includes one share of series A senior convertible preferred stock and one warrant to purchase one common share, according to the company.The units were priced at $4 apiece with a $4 conversion price of preferred stock into one common share and a $4.40 per share exercise price of the warrants, OS Therapies added.The company said proceeds from the private placement will be used for working capital and general capital purposes.OS Therapies expects the capital raised to sustain operations into 2026 and anticipates delivering clinical data and biologics license application requirements needed to obtain US Food and Drug Administration authorization for the commercialization of OST-HER2 to prevent recurrent, resected metastatic osteosarcoma in the US.Shares of OS Therapies were down more than 10% in recent trading.Price: 4.22, Change: -0.48, Percent Change: -10.15","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2500864737","title":"Os Therapies Announces Closing of $6 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2500864737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500864737?lang=en_us&edition=fundamental","pubTime":"2025-01-01 04:38","pubTimestamp":1735677480,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUA48T85Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2494863263","title":"Sector Update: Health Care Stocks Steady Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2494863263","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494863263?lang=en_us&edition=fundamental","pubTime":"2024-12-26 22:09","pubTimestamp":1735222195,"startTime":"0","endTime":"0","summary":"Health care stocks were steady premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently.TScan Therapeutics (TCRX) shares rose past","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4581","IBB","BK4167","XLV","BK4539","BK4585","TCRX","OSTX","MPLN","BK4588"],"gpt_icon":0},{"id":"2494205962","title":"BRIEF-OS Therapies Announces Pricing Of $6 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2494205962","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494205962?lang=en_us&edition=fundamental","pubTime":"2024-12-25 05:08","pubTimestamp":1735074507,"startTime":"0","endTime":"0","summary":"BRIEF-OS Therapies Announces Pricing Of $6 Million Private PlacementDec 24 (Reuters) - OS Therapies Inc OSTX.A:OS THERAPIES ANNOUNCES PRICING OF $6 MILLION PRIVATE PLACEMENTOS THERAPIES INC - FUNDING ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nTUA9HQYGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2493080165","title":"OS Therapies Shares Jump on $6 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493080165","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493080165?lang=en_us&edition=fundamental","pubTime":"2024-12-24 23:02","pubTimestamp":1735052520,"startTime":"0","endTime":"0","summary":"Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement.The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58.The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share.The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2493080538","title":"OS Therapies Prices $6 Million Private Placement; Shares Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2493080538","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493080538?lang=en_us&edition=fundamental","pubTime":"2024-12-24 22:56","pubTimestamp":1735052174,"startTime":"0","endTime":"0","summary":"OS Therapies  said Tuesday that it signed securities purchase agreements with investors to sell 1.5 million units at $4 each for gross proceeds of $6 million.Each unit consists of one share of series A senior convertible preferred stock, initially convertible into one share of common stock and one warrant to purchase one common share. The preferred stock is convertible into shares at $4, while the warrants are exercisable at $4.40 per share, the company said.The offering is expected to close on or about Friday.OS Therapies said it will use the proceeds for working capital, particularly related to the clinical and regulatory milestones of lead therapeutic candidate OST-HER2 to treat recurrent, resected metastatic osteosarcoma in the US, and for general corporate purposes.Shares of the company surged more than 17% in recent trading.Price: 4.44, Change: +0.66, Percent Change: +17.46","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2493087870","title":"OS Therapies to sell 1.5M units at $4.00 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087870","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493087870?lang=en_us&edition=fundamental","pubTime":"2024-12-24 22:40","pubTimestamp":1735051227,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced that it has entered into securities purchase agreements with investors to sell 1.5M units at a price of $4.00 per uni...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-to-sell-1-5m-units-at-4-00-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-to-sell-1-5m-units-at-4-00-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSTX"],"gpt_icon":0},{"id":"2493826940","title":"Os Therapies Announces Pricing of $6 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493826940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493826940?lang=en_us&edition=fundamental","pubTime":"2024-12-24 22:32","pubTimestamp":1735050720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nTUA9HQYGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OSTX"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":105,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OSTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OSTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OSTX","date":"2025-06-13","current":-4.574874,"percent":0.80543,"low":-14.897496,"twenty":-11.315425,"median":-7.167274,"eighty":-4.590507,"high":-2.731469,"avg":-7.723832,"sd":3.415038,"marketCap":51699762},"quantilePoints":[{"date":"2024-06-14","current":-13.217965,"twenty":-13.216533,"median":-13.214385,"eighty":-13.212238,"marketCap":102988885},{"date":"2024-06-21","current":-10.574372,"twenty":-13.217965,"median":-13.214385,"eighty":-12.156232,"marketCap":82391108},{"date":"2024-06-28","current":-13.217965,"twenty":-13.217965,"median":-13.217965,"eighty":-13.210806,"marketCap":102988885},{"date":"2024-08-02","current":-6.458845,"twenty":-13.217965,"median":-13.217965,"eighty":-11.101659,"marketCap":50324634},{"date":"2024-08-09","current":-8.117559,"twenty":-13.217965,"median":-10.433676,"eighty":-8.215548,"marketCap":63248641},{"date":"2024-08-16","current":-10.993719,"twenty":-13.216533,"median":-10.29298,"eighty":-8.15204,"marketCap":70975778},{"date":"2024-08-23","current":-13.004275,"twenty":-13.182439,"median":-10.833368,"eighty":-8.309008,"marketCap":83955991},{"date":"2024-08-30","current":-11.710317,"twenty":-13.188909,"median":-11.710317,"eighty":-8.610078,"marketCap":75602161},{"date":"2024-09-06","current":-12.939577,"twenty":-13.217965,"median":-12.391225,"eighty":-8.620371,"marketCap":83538300},{"date":"2024-09-13","current":-11.32213,"twenty":-13.217965,"median":-12.261039,"eighty":-9.289415,"marketCap":73096012},{"date":"2024-09-20","current":-11.483875,"twenty":-13.217965,"median":-11.710317,"eighty":-10.29298,"marketCap":74140241},{"date":"2024-09-27","current":-9.575287,"twenty":-13.210806,"median":-11.435351,"eighty":-9.575287,"marketCap":61818342},{"date":"2024-10-04","current":-9.727327,"twenty":-13.101322,"median":-11.354479,"eighty":-9.316172,"marketCap":62799917},{"date":"2024-10-11","current":-9.931126,"twenty":-13.068973,"median":-11.192735,"eighty":-9.413543,"marketCap":64115645},{"date":"2024-10-18","current":-9.769381,"twenty":-13.068973,"median":-10.859351,"eighty":-9.542938,"marketCap":63071416},{"date":"2024-10-25","current":-9.413543,"twenty":-13.004275,"median":-10.610453,"eighty":-9.542938,"marketCap":60774113},{"date":"2024-10-31","current":-8.782738,"twenty":-12.952517,"median":-10.592413,"eighty":-9.394069,"marketCap":56701621},{"date":"2024-11-08","current":-9.085848,"twenty":-12.836061,"median":-10.29298,"eighty":-9.218608,"marketCap":58658505},{"date":"2024-11-15","current":-7.116768,"twenty":-12.603148,"median":-10.141393,"eighty":-8.950952,"marketCap":45946065},{"date":"2024-11-22","current":-5.272053,"twenty":-12.423258,"median":-9.769381,"eighty":-8.605027,"marketCap":38782655},{"date":"2024-11-29","current":-6.178419,"twenty":-12.235002,"median":-9.759676,"eighty":-8.507772,"marketCap":45450128},{"date":"2024-12-06","current":-5.370028,"twenty":-11.917351,"median":-9.716005,"eighty":-8.143742,"marketCap":39503383},{"date":"2024-12-13","current":-12.876517,"twenty":-11.917351,"median":-9.704683,"eighty":-7.804035,"marketCap":94723165},{"date":"2024-12-20","current":-11.288606,"twenty":-11.937313,"median":-9.73218,"eighty":-8.125896,"marketCap":83042057},{"date":"2024-12-27","current":-14.738704,"twenty":-12.001827,"median":-9.761941,"eighty":-8.139646,"marketCap":108421919},{"date":"2025-01-03","current":-12.068126,"twenty":-12.384347,"median":-9.850254,"eighty":-8.168424,"marketCap":88776420},{"date":"2025-01-10","current":-14.782011,"twenty":-12.810182,"median":-10.086184,"eighty":-8.234384,"marketCap":108740495},{"date":"2025-01-17","current":-11.8949,"twenty":-12.876517,"median":-10.189917,"eighty":-8.475423,"marketCap":87502117},{"date":"2025-01-24","current":-8.430366,"twenty":-12.823449,"median":-10.125219,"eighty":-8.466412,"marketCap":62016063},{"date":"2025-01-31","current":-5.629868,"twenty":-12.632281,"median":-9.850254,"eighty":-8.128675,"marketCap":41414837},{"date":"2025-02-07","current":-5.600996,"twenty":-12.558673,"median":-9.759676,"eighty":-7.471942,"marketCap":41202453},{"date":"2025-02-14","current":-5.745352,"twenty":-12.423258,"median":-9.716005,"eighty":-6.985183,"marketCap":42264372},{"date":"2025-02-21","current":-5.456641,"twenty":-12.370592,"median":-9.688508,"eighty":-6.36129,"marketCap":40140534},{"date":"2025-02-28","current":-4.734863,"twenty":-12.322192,"median":-9.575287,"eighty":-6.039722,"marketCap":34830939},{"date":"2025-03-07","current":-4.850347,"twenty":-12.19815,"median":-9.413543,"eighty":-5.818713,"marketCap":35680475},{"date":"2025-03-14","current":-4.619378,"twenty":-12.093217,"median":-9.316172,"eighty":-5.658739,"marketCap":33981404},{"date":"2025-03-21","current":-4.590507,"twenty":-12.033481,"median":-9.267973,"eighty":-5.589448,"marketCap":33769021},{"date":"2025-03-28","current":-4.677121,"twenty":-11.941094,"median":-9.085848,"eighty":-5.445093,"marketCap":34406172},{"date":"2025-04-04","current":-3.682014,"twenty":-11.842932,"median":-9.000397,"eighty":-5.346931,"marketCap":32707102},{"date":"2025-04-11","current":-2.731469,"twenty":-11.788323,"median":-8.747948,"eighty":-5.012916,"marketCap":24263468},{"date":"2025-04-17","current":-3.828934,"twenty":-11.749136,"median":-8.669517,"eighty":-4.901959,"marketCap":34012183},{"date":"2025-04-25","current":-3.926486,"twenty":-11.61974,"median":-8.601309,"eighty":-4.833024,"marketCap":34878735},{"date":"2025-05-02","current":-4.706906,"twenty":-11.475058,"median":-8.516979,"eighty":-4.792605,"marketCap":41811155},{"date":"2025-05-09","current":-4.804459,"twenty":-11.45771,"median":-8.491597,"eighty":-4.792605,"marketCap":42677707},{"date":"2025-05-16","current":-4.048427,"twenty":-11.438586,"median":-8.234384,"eighty":-4.718089,"marketCap":35961926},{"date":"2025-05-23","current":-2.933033,"twenty":-11.406237,"median":-8.124506,"eighty":-4.677121,"marketCap":33145630},{"date":"2025-05-30","current":-3.928425,"twenty":-11.380358,"median":-7.63641,"eighty":-4.64825,"marketCap":44394361},{"date":"2025-06-06","current":-4.052742,"twenty":-11.348009,"median":-7.333748,"eighty":-4.596281,"marketCap":45799246},{"date":"2025-06-13","current":-4.574874,"twenty":-11.315425,"median":-7.167274,"eighty":-4.590507,"marketCap":51699762}],"updateTime":1750065794376}}}